Literature DB >> 7551886

Neomycin-induced perception deafness following bladder irrigation in patients with end-stage renal disease.

E W Gerharz1, K Weingärtner, M D Melekos, S Varga, H Feiber, H Riedmiller.   

Abstract

OBJECTIVE: To report a serious side-effect of intravesical instillations of neomycin in patients with end-stage renal disease. PATIENTS AND METHODS: Three patients (two men and a woman, aged 51.71 and 54 respectively) with end-stage renal disease who had undergone bladder irrigation with neomycin sulphate solution suffered complete irreversible deafness, which was assessed by audiogram.
RESULTS: All three patients developed complete perception deafness after 3, 4 and 10 months, with characteristic changes in the audiogram. The severe progressive hearing loss was maximal in the high-frequency range. A high-pitched tinnitus was the first sign of impending hearing difficulty and two patients developed a spontaneous nystagmus.
CONCLUSION: In view of the doubtful efficacy and, most importantly, the risk of severe disabling side-effects such as ototoxicity, we recommend the avoidance of intravesical instillation with neomycin whenever possible.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7551886     DOI: 10.1111/j.1464-410x.1995.tb07750.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  3 in total

1.  Use of intravesicular amikacin irrigations for the treatment and prophylaxis of urinary tract infections in a patient with spina bifida and neurogenic bladder: a case report.

Authors:  Donna Huynh; Jill A Morgan
Journal:  J Pediatr Pharmacol Ther       Date:  2011-04

Review 2.  Recurrent urinary tract infections in patients with incomplete bladder emptying: is there a role for intravesical therapy?

Authors:  Elizabeth V Dray; J Quentin Clemens
Journal:  Transl Androl Urol       Date:  2017-07

Review 3.  Use and Effectiveness of Antimicrobial Intravesical Treatment for Prophylaxis and Treatment of Recurrent Urinary Tract Infections (UTIs): a Systematic Review.

Authors:  Amelia Pietropaolo; Patrick Jones; Mike Moors; Brian Birch; Bhaskar K Somani
Journal:  Curr Urol Rep       Date:  2018-08-09       Impact factor: 3.092

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.